Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,126 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06840119 | Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers | recruiting | Phase 1 / Phase 2 | 600 | Immunocore LtdINDUSTRY | 6 | Jan 28, 2026 | clinicaltrials |
| NCT06923761 | EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)(EMITT-1) | recruiting | Phase 1 / Phase 2 | 300 | Grey Wolf TherapeuticsOTHER | 4 | Jan 28, 2026 | clinicaltrials |
| NCT07151040 |
| Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors(ODIN) |
| recruiting |
| Phase 1 / Phase 2 |
| 43 |
| One-carbon Therapeutics ABINDUSTRY |
| 3 |
| Jan 28, 2026 |
| clinicaltrials |
| NCT05855200 | Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer | recruiting | Phase 3 | 892 | GlaxoSmithKlineINDUSTRY | 28 | Jan 23, 2026 | clinicaltrials |
| NCT05861245 | Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base | recruiting | N/A | 20 | QuironsaludOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07364955 | Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma | recruiting | N/A | 75 | Albert Torrents TorreroOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT06694519 | Radiofrequency and Exercise-based Rehabilitation on Symptoms Associated With Pelvic Floor Dysfunctions in Breast Cancer | recruiting | N/A | 117 | SERGIO MONTERO NAVARROOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07240935 | Spanish Validation of a Psychosocial Needs Assessment for Adolescents and Young Adults With Cancer (AYA-POST) | recruiting | N/A | 100 | Hospital Universitari Vall d'Hebron Research InstituteOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT06712459 | Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma | recruiting | — | 100 | International Extranodal Lymphoma Study Group (IELSG)OTHER | 7 | Jan 16, 2026 | clinicaltrials |
| NCT07231458 | A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies | recruiting | Phase 1 | 27 | Abalos Therapeutics GmbHINDUSTRY | 2 | Jan 16, 2026 | clinicaltrials |
| NCT07107594 | Multimodal Prehabilitation Program That Combines Physical Exercise, Psychological Intervention and Nutritional Support to Improve the Response to Neoadjuvant Chemoterhapy in Early Breast Cancer Patients(DIANA) | recruiting | N/A | 214 | Hospital Clinic of BarcelonaOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT06163430 | A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)(CARDINAL) | recruiting | Phase 1 / Phase 2 | 180 | Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 9 | Jan 12, 2026 | clinicaltrials |
| NCT05270096 | International Leukemia Target Board(iLTB) | recruiting | — | 600 | Princess Maxima Center for Pediatric OncologyOTHER | 7 | Jan 9, 2026 | clinicaltrials |
| NCT06265727 | A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors | recruiting | Phase 1 / Phase 2 | 348 | Corbus Pharmaceuticals Inc.INDUSTRY | 7 | Jan 8, 2026 | clinicaltrials |
| NCT02986516 | Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease(SACRO) | recruiting | N/A | 100 | Italian Sarcoma GroupNETWORK | 10 | Jan 2, 2026 | clinicaltrials |
| NCT06531499 | A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study(RADIODOSE) | recruiting | Phase 1 | 106 | Novartis PharmaceuticalsINDUSTRY | 6 | Dec 31, 2025 | clinicaltrials |
| NCT07310693 | External Validation of the CLOVER Score for Detecting Occult Cancer in Venous Thromboembolism Patients(CLOVER) | recruiting | — | 500 | Infanta Leonor University HospitalOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT06690775 | CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. | recruiting | Phase 2 | 230 | TORL Biotherapeutics, LLCINDUSTRY | 12 | Dec 23, 2025 | clinicaltrials |
| NCT07299292 | Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2) | recruiting | Phase 2 | 60 | SMED Clinical ResearchOTHER | 2 | Dec 23, 2025 | clinicaltrials |
| NCT06511648 | Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations(SOGUG-NEOWIN) | recruiting | Phase 2 | 90 | Spanish Oncology Genito-Urinary GroupOTHER | 4 | Dec 19, 2025 | clinicaltrials |
| NCT06963268 | Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)(SENTOV II) | recruiting | Phase 3 | 200 | Instituto de Investigacion Sanitaria La FeOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT03567889 | Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients(NeoDREAM) | recruiting | Phase 3 | 186 | Philogen S.p.A.INDUSTRY | 3 | Dec 17, 2025 | clinicaltrials |
| NCT05259605 | Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification | recruiting | — | 1,650 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Dec 17, 2025 | clinicaltrials |
| NCT05856981 | Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors | recruiting | Phase 1 | 130 | Sairopa B.V.INDUSTRY | 3 | Dec 17, 2025 | clinicaltrials |
| NCT06717919 | HOPE Against Cancer Recurrence in HCC(HOPE4Cancer) | recruiting | Phase 4 | 220 | Philipp DutkowskiOTHER | 17 | Dec 16, 2025 | clinicaltrials |
| NCT07284277 | TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC) | recruiting | Phase 1 / Phase 2 | 30 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT07285590 | Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma(IMCL-2023) | recruiting | Phase 2 | 50 | Grupo Español de Linfomas y Transplante Autólogo de Médula ÓseaOTHER | 2 | Dec 16, 2025 | clinicaltrials |
| NCT07281248 | TRIMODAL PREHABILITATION IN GASTROINTESTINAL CANCER(PREDIGEST) | recruiting | N/A | 30 | Puerta de Hierro University HospitalOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT06465433 | Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab | recruiting | Phase 2 | 25 | Incyte CorporationINDUSTRY | 5 | Dec 10, 2025 | clinicaltrials |
| NCT07249060 | Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients(INTER-AUTENTIC) | recruiting | — | 300 | Hospital Universitario ArabaOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT07251413 | Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma(CEMIQUID) | recruiting | Phase 1 / Phase 2 | 18 | Instituto Oncológico Dr RosellOTHER | 1 | Dec 1, 2025 | clinicaltrials |
| NCT07254754 | Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma(LATE-R-GEL-23) | recruiting | Phase 2 | 45 | Grupo Español de Linfomas y Transplante Autólogo de Médula ÓseaOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT06146231 | Motiva Flora® Aesthetic Breast Recon® Clinical Study | recruiting | N/A | 66 | Establishment LabsINDUSTRY | 4 | Nov 26, 2025 | clinicaltrials |
| NCT05547321 | Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors. | recruiting | Phase 1 | 150 | Oncomatryx Biopharma S.L.INDUSTRY | 2 | Nov 25, 2025 | clinicaltrials |
| NCT07128030 | Moderate-Intensity Exercise and Pain Sensitization in Breast Cancer Survivors: A Case-Based Study | recruiting | N/A | 10 | Universidad Rey Juan CarlosOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT06917573 | PALACE: Cemiplimab Trial According to ctDNA Levels(PALACE) | recruiting | Phase 2 | 63 | Fundación GECPOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT07153445 | Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC)(ATHENEA) | recruiting | Phase 2 | 97 | Fundación GECPOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT04652609 | Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program(PRESIONA) | recruiting | N/A | 25 | Universidad de GranadaOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07229040 | A Double-blind Non Inferiority Clinical Trial to Compare the Nephroprotection of Cilastatn Versus Thiosulfate in Patients Undergoing Debulking Surgery With Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Cisplatin. | recruiting | Phase 2 | 90 | Hospital General Universitario Gregorio MarañonOTHER | 1 | Nov 14, 2025 | clinicaltrials |
| NCT06376162 | Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia | recruiting | Phase 1 | 20 | PedAL BCU, LLCOTHER | 7 | Oct 20, 2025 | clinicaltrials |
| NCT06174987 | A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s) | recruiting | Phase 3 | 50 | Daiichi SankyoINDUSTRY | 12 | Oct 15, 2025 | clinicaltrials |
| NCT04954599 | Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI | recruiting | Phase 1 / Phase 2 | 126 | Maastricht University Medical CenterOTHER | 3 | Oct 7, 2025 | clinicaltrials |
| NCT05211570 | AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia | recruiting | Phase 1 / Phase 2 | 78 | AB ScienceINDUSTRY | 4 | Oct 2, 2025 | clinicaltrials |
| NCT06696534 | Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme(MS-Care) | recruiting | N/A | 1,000 | ADVANCED MARKER DISCOVERY S.L.INDUSTRY | 2 | Oct 2, 2025 | clinicaltrials |
| NCT06887088 | Encorafenib and biNimetinib Followed by CEmiplimab and FiAnLimab in Patients With BRAF Mutant melanOma and Symptomatic Brain Metastases(ENCEFALO) | recruiting | Phase 2 | 33 | Grupo Español Multidisciplinar de MelanomaOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT06889844 | Observational Cross-reactivity Study for Colorectal Cancer Diagnosis | recruiting | — | 250 | ADVANCED MARKER DISCOVERY S.L.INDUSTRY | 1 | Oct 1, 2025 | clinicaltrials |
| NCT06889883 | Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer(ColoDix) | recruiting | — | 510 | ADVANCED MARKER DISCOVERY S.L.INDUSTRY | 1 | Oct 1, 2025 | clinicaltrials |
| NCT05322460 | Web-based Intervention for Long-term Breast Cancer Survivors(CUMACA-M) | recruiting | N/A | 182 | Cristina García-VivarOTHER | 1 | Sep 30, 2025 | clinicaltrials |
| NCT07190066 | MELIORA Data Collection Campaigns(DCC) | recruiting | N/A | 300 | Harokopio UniversityOTHER | 4 | Sep 30, 2025 | clinicaltrials |
| NCT05988645 | Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II) | recruiting | N/A | 50 | MiWEndo Solutions S.L.INDUSTRY | 1 | Sep 29, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials